137
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Cell Cycle Arrest and Induction of Apoptosis in Colon Adenocarcinoma Cells by a DNA Intercalative Quinoline Derivative, 4-Morpholinopyrimido [4′,5′:4,5] Selenolo (2,3-b) Quinoline

, , , &
Pages 525-543 | Received 19 Nov 2014, Accepted 12 Mar 2015, Published online: 13 Jul 2015

REFERENCES

  • Sadikovic, B.; Al-Romaih, K.; Squire, J.A.; Zielenska, M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr. Genomics 2008, 9, 394–408.
  • Robison, K. Application of second-generation sequencing to cancer genomics. Brief Bioinform 2010, 11, 524–534.
  • Shahabuddin, M.S.; Nambiar, M.; Choudhary, B.; Advirao, G.M.; Raghavan, S.C. A novel DNA intercalator, butylamino-pyrimido[4′,5′:4,5] selenolo (2,3-b) quinoline, induces cell cycle arrest and apoptosis in leukemic cells. Invest. New Drugs 2010, 28, 35–48.
  • Kastan, M.B.; Bartek, J. Cell-cycle checkpoints and cancer. Nature 2004, 432, 316–323.
  • Hurley, L.H. DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer 2002, 2, 188–200.
  • Gurova, K. New hopes from old drugs: Revisiting DNA-binding small molecules as anticancer agents. Future Oncol. 2009, 5, 1685.
  • Martínez, R.; Chacón-García, L. The search of DNA-intercalators as antitumoral drugs: What it worked and what did not work. Curr. Med. Chem. 2005, 12, 127–151.
  • Li, S.; Cooper, V.R.; Thonhauser, T.; Lundqvist, B.I.; Langreth, D.C. Stacking interactions and DNA intercalation. J. Phys. Chem. B 2009, 113, 11166–11172.
  • Ralph, R.K.; Marshall, B.; Darkin, S. Anticancer drugs which intercalate into DNA: How do they act? Trends. Biochem. Sci. 1982, 8, 212–214.
  • Huang, Y.-T.; Huang, D.-M.; Guh, J.-H.; Chen, I.-L.; Tzeng, C.-C.; Teng, C.-M. CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line. J. Biol. Chem. 2005, 280, 2771–2779.
  • Hengartner, M.O. The biochemistry of apoptosis. Nature 2000, 407, 770–776.
  • Gavrilescu, L.C.; Denkers, E.Y. Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection. Infect. Immun. 2003, 71, 6109–6115.
  • Hannun, Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997, 89, 1845–1853.
  • Nandeeshaiah, S.K.; Ambekar, S.Y. Synthesis, dimroth rearrangement and blood platelet disaggregation property of pyrimido[4′,5′:4,5] selenolo [2,3-b] quinolines: A new class of condensed quinoline. Indian J. Chem. B 1998, 37, 995–1000.
  • Kohn, K.W.; Waring, M.J.; Glaubiger, D.; Friedman, C.A. Intercalative binding of ellipticine to DNA. Cancer Res. 1975, 35, 71–76.
  • Stiborova, M.; Rupertova, M.; Schmeiser, H.H.; Frei, E. Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2006, 150, 13–23.
  • Stiborová, M.; Poljaková, J.; Martínková, E.; Bořek-Dohalská, L.; Eckschlager, T.; Kizek, R.; Frei, E. Ellipticine cytotoxicity to cancer cell lines – a comparative study. Interdiscip. Toxicol. 2011, 4, 98–105.
  • Kuo, P.-L.; Hsu, Y.-L.; Chang, C.-H.; Lin, C.-C. The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells. Cancer Lett. 2005, 223, 293–301.
  • Djuric, Z.; Everett, C.K.; Valeriote, F.A. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(Diethylaminoethyl)-9-hydroxyellipticinium chloride. Cancer Res. 1992, 52, 1515–1519.
  • Ferlin, M.G.; Marzano, C.; Gandin, V.; Dall’Acqua, S.; Dalla Via, L. DNA binding ellipticine analogues: Synthesis, biological evaluation, and structure-activity relationships. Chem. Med. Chem. 2009, 4, 363–377.
  • Prajapati, S.M.; Patel, K.D.; Vekariya, R.H.; Panchal, S.N.; Patel, H.D. Recent advances in the synthesis of quinolines: A review. RSC Adv. 2014, 4, 24463–24476.
  • Solomon, V.R.; Lee, H. Quinoline as a privileged scaffold in cancer drug discovery. Curr. Med. Chem. 2011, 18, 1488–1508.
  • Shahabuddin, M.S.; Gopal, M.; Raghavan, S.C. Intercalating, cytotoxic, antitumour activity of 8-chloro and 4-morpholinopyrimido [4′,5′:4,5]thieno(2,3-b)quinolines. J. Photochem. Photobiol. B 2009, 94, 13–19.
  • Shahabuddin, M.S.; Gopal, M.; Raghavan, S.C. Intercalating and antitumour activity of 4-oxopyrimido [4′,5′:4,5] thieno (2,3-b) quinoline-4(3H)-one. J. Cancer Mol. 2007, 3, 139–146.
  • Shahabuddin, M.S.; Nambiar, M.; Moorthy, B.T.; Naik, P.L.; Choudhary, B.; Advirao, G.M.; Raghavan, S.C. A novel structural derivative of natural alkaloid ellipticine, MDPSQ, induces necrosis in leukemic cells. Invest. New Drugs 2011, 29, 523–533. doi: 10.1007/s10637-009-9379-5.
  • Gopal, M.; Veeranna, S.; Doddamani, L. Intercalation binding of 4-butylaminopyrim-ido[4′,5′:4,5]selenolo (2,3-b) quinoline to DNA: Relationship with in vitro cytotoxicity. Spectrosc. Lett. 2004, 37, 347–366.
  • Gopal, M.; Veeranna, S. Interaction of 4-benzylaminopyrimido[4′,5′:4,5] selenolo (2,3-b) quinoline with DNA fragments: A circular dichroism study. Res. Chem. Intermediat. 2005, 31, 737–745.
  • Ren, J.; Chaires, J.B. Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry 1999, 38, 16067–16075.
  • Benesi, H.A.; Hildebrand, J.H. A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J. Am. Chem. Soc. 1949, 71, 2703–2707.
  • Huo, D.; Yang, L.; Hou, C.; Fa, H.; Luo, X.; Lu, Y.; Zheng, X.; Yang, J.; Yang, L. Molecular interactions of monosulfonate tetraphenylporphyrin (TPPS1) and meso-tetra(4-sulfonatophenyl)porphyrin (TPPS) with dimethyl methylphosphonate (DMMP). Spectrochim. Acta A 2009, 74, 336–343.
  • Cao, Y.; He, X.W. Studies of interaction between safranine T and double helix DNA by spectral methods. Spectrochim. Acta A 1998, 54A, 883–892.
  • Tu, L.C.; Chen, C.-S.; Hsiao, I.-C.; Chern, J.-W.; Lin, C.-H.; Shen, Y.-C.; Yeh, S.F. The beta-carboline analog Mana-Hox causes mitotic aberration by interacting with DNA. Chem. Biol. 2005, 12, 1317–1324.
  • Canals, A.; Purciolas, M.; Aymamí, J.; Coll, M. The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs. Acta Crystallogr. D 2005, 61, 1009–1012.
  • Ritchie, D.W.; Kemp, G.J. Protein docking using spherical polar Fourier correlations. Proteins 2000, 39, 178–194.
  • Hegde, M.; Karki, S.S.; Thomas, E.; Kumar, S.; Panjamurthy, K.; Ranganatha, S.R.; Rangappa, K.S.; Choudhary, B.; Raghavan, S.C. Novel levamisole derivative induces extrinsic pathway of apoptosis in cancer cells and inhibits tumor progression in mice. PLoS One 2012, 7, e43632.
  • Kavitha, C.V.; Nambiar, M.; Ananda Kumar, C.S.; Choudhary, B.; Muniyappa, K.; Rangappa, K.S.; Raghavan, S.C. Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochem. Pharmacol. 2009, 77, 348–363.
  • Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 1995, 184, 39–51.
  • Mukhopadhyay, P.; Rajesh, M.; Haskó, G.; Hawkins, B.J.; Madesh, M.; Pacher, P. Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat. Protoc. 2007, 2, 2295–2301.
  • Mehta, A.; Shaha, C. Mechanism of metalloid-induced death in Leishmania spp.: Role of iron, reactive oxygen species, Ca2+, and glutathione. Free Radic. Biol. Med. 2006, 40, 1857–1868.
  • Piantanida, I.; Palm, B.S.; Zinić, M.; Schneider, H.-J. A new 4,9-diazapyrenium intercalator for single- and double-stranded nucleic acids: distinct differences from related diazapyrenium compounds and ethidium bromide. J. Chem. Soc. Perkin. Trans. 2001, 2, 1808–1816.
  • Amutha, R.; Subramanian, V.; Nair, B.U. Interaction of benzidine with DNA: Experimental and modeling studies. Chem. Phys. Lett. 2001, 344, 40–48.
  • Vermeulen, K.; Van Bockstaele, D.R.; Berneman, Z.N. Apoptosis: Mechanisms and relevance in cancer. Ann. Hematol. 2005, 84, 627–639.
  • Demeunynck, M.; Bailley, C.; Wilson, W.D. From Small Molecules to Drugs. DNA and RNA Binders, Wiley-VCH, New York, NY, 2003, pp. 482–497.
  • Zhou, C.; Wu, Y.; Yang, P. Synthesis, characterization, and studies on DNA binding of the complex Fe(Sal2dienNO3,H2O). Biochemistry (Moscow) 2010, 75, 505–512.
  • Garrett, R.H.; Grisham, C.M. Biochemistry, Cengage Learning, Boston, MA, 2010, pp. 316–353.
  • Lo, Y.-S.; Tseng, W.-H.; Chuang, C.-Y.; Hou, M.-H. The structural basis of actinomycin D-binding induces nucleotide flipping out, a sharp bend and a left-handed twist in CGG triplet repeats. Nucleic Acids Res. 2013, 41, 4284–4294.
  • Gewirtz, D.A. A critical evaluation of the mechanisms of action proposed for the antitumour effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 1999, 57, 727–741.
  • Nelson, S.M.; Ferguson, L.R.; Denny, W.A. DNA and the chromosome-varied targets for chemotherapy. Cell Chromosome 2004, 3, 2.
  • Cattaneo-Pangrazzi, R.M.; Schott, H.; Wunderli-Allenspach, H.; Rothen-Rutishauser, B.; Guenthert, M.; Schwendener, R.A. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells. J. Cancer Res. Clin. Oncol. 2000, 126, 247–256.
  • Leonce, S.; Pérez, V.; Lambel, S.; Peyroulan, D.; Tillequin, F.; Michel, S.; Koch, M.; Pfeiffer, B.; Atassi, G.; Hickman, J.A.; Pierré, A. Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis. Mol. Pharmacol. 2001, 60, 1383–1391.
  • Chen, H.Y.; Zheng, C.Y.; Zou, G.L.; Xie, D.X.; Gong, J.P. Peplomycin induces G1 phase specific apoptosis in liver carcinoma cell line Bel-7402 involving G2 phase arrest. Acta Pharmacol. Sin. 2004, 25, 1698–1704.
  • Cheah, Y.H.; Nordin, F.J.; Sarip, R.; Tee, T.T.; Azimahtol, H.L.P.; Sirat, H.M.; Rashid, B.A.A.; Abdullah, N.R.; Ismail, Z. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int. 2009, 9, 1.
  • Kroemer, G.; Galluzzi, L.; Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87, 99–163.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.